Mutations in LRRK2 other than G2019S are rare in a north american–based sample of familial Parkinson's disease
✍ Scribed by Nathan Pankratz; Michael W. Pauciulo; Veronika E. Elsaesser; Diane K. Marek; Cheryl A. Halter; Alice Rudolph; Clifford W. Shults; Tatiana Foroud; William C. Nichols
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 64 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
A total of 956 individuals with Parkinson's disease (PD) from 430 multiplex PD pedigrees were screened for 12 previously reported, pathogenic LRRK2 mutations: R793M, L1114L, I1371V, R1441C, R1441G, R1441H, Y1699C, M1869T, I2012T, I2020T, G2385R, and IVS31 +3G>A. Previous screening identified the LRRK2 G2019S mutation in 5% of our families. Only 1 of the 12 newly screened mutations, R1441C, was detected in a single family in our patient cohort. These results indicate that, although the G2019S mutation remains the most common mutation identified in familial PD patients, other mutations in LRRK2 are infrequent. © 2006 Movement Disorder Society
📜 SIMILAR VOLUMES
## Abstract Mutations in the leucine‐rich repeat kinase 2 (__LRRK2__) gene have been shown to cause autosomal dominant and sporadic Parkinson's disease (PD). We report here the frequency of a common heterozygous mutation, 2877510G>A, which produces a glycine‐to‐serine amino acid substitution at cod